Welcome to CDC stacks | A new antituberculosis drug? - 71744 | Public Health Reports
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A new antituberculosis drug?
  • Published Date:
    Sep 1952
  • Source:
    Public Health Rep. 67(9):848-850
  • Language:
    English
Filetype[PDF-457.81 KB]


Details:
  • Supporting Files:
    No Additional Files
You May Also Like:
  1. The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.
    Personal Author:
    Villarino, Margarita E.; Geiter, Lawrence J.; Simone, Patricia M.;
    Published:
    1992 Nov-Dec
    Source:
    Public Health Rep. 107(6):616-625
    Description:
    After years of steady decline, there has been an unprecedented resurgence of tuberculosis (TB) in the United States and outbreaks of multidrug-resistant tuberculosis (MDR-TB). The authors assess the nature, epidemiology, and implications of MDR-TB; p...
    File Type:
    Filetype[PDF - 1.99 MB]
  2. Supplementing tuberculosis surveillance with automated data from health maintenance organizations.
    Personal Author:
    Yokoe, D. S.; Subramanyan, G. S.; Nardell, E.; Sharnprapai, S.; McCray, E.; Platt, R.;
    Published:
    1999 Nov-Dec
    Source:
    Emerg Infect Dis. 5(6):779-787.
    Description:
    Data collected by health maintenance organizations (HMOs), which provide care for an increasing number of persons with tuberculosis (TB), may be used to complement traditional TB surveillance. We evaluated the ability of HMO-based surveillance to con...
    File Type:
    Filetype[PDF - 82.91 KB]
  3. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus; principles of therapy and revised recommendations
    Personal Author:
    Villarino, M. Elsa
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination..
    Conference Author:
    CDC Conference on HIV-Related Tuberculosis (1997 : Atlanta, Georgia)
    Published:
    October 30, 1998
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 47, no. 20
    Description:
    "These guidelines update previous CDC recommendations for the diagnosis, treatment, and prevention of tuberculosis (TB) among adults and children coinfected with human immunodeficiency virus (HIV) in the United States. The most notable changes in the...
    Status:
    superseded
    File Type:
    Filetype[PDF - 743.08 KB]
  4. Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB
    Personal Author:
    de Steenwinkel, Jurriaan E.M.; ten Kate, Marian T.; de Knegt, Gerjo J.; Kremer, Kristin; Aarnoutse, Rob E.; Boeree, Martin J.; Verbrugh, Henri A.; van Soolingen, Dick; Bakker-Woudenberg, Irma A.J.M.;
    Published:
    Apr 2012
    Source:
    Emerg Infect Dis. 18(4):660-663.
    Description:
    To determine differences in the ability of Mycobacterium tuberculosis strains to withstand antituberculosis drug treatment, we compared the activity of antituberculosis drugs against susceptible Beijing and East-African/Indian genotype M. tuberculosi...
    File Type:
    Filetype[PDF - 378.24 KB]
  5. Treatment of tuberculosis
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). American Thoracic Society.. Infectious Diseases Society of America..
    Published:
    June 20, 2003
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2003; 52(RR-11):1-77.
    Series:
    Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-11
    American journal of respiratory and critical care medicine ; v. 167, p. 603-662
    Description:
    "The recommendations in this document are intended to guide the treatment of tuberculosis in settings where mycobacterial cultures, drug susceptibility testing, radiographic facilities, and second-line drugs are routinely available. In areas where th...
    Status:
    current
    File Type:
    Filetype[PDF - 1.46 MB]